Lucio N. Gordan, MD, Joins NCODA Board to Strengthen Patient-Centered Oncology Care Leadership

NCODA Welcomes Dr. Lucio N. Gordan to Its Board of Directors

In a significant move aimed at bolstering leadership in patient-centered oncology care, the National Community Oncology Dispensing Association (NCODA) has announced the appointment of Dr. Lucio N. Gordan to its Board of Directors. Dr. Gordan, who serves as the president and managing physician at Florida Cancer Specialists & Research Institute, brings an extensive background in oncology that promises to enhance NCODA's mission of empowering community oncology practices.

Dr. Gordan is recognized as a pioneering leader in the oncology field, having played a crucial role in elevating Florida Cancer Specialists to one of the leading cancer treatment and research centers in the nation. His expertise in guiding innovative, patient-focused healthcare initiatives aligns seamlessly with NCODA's objective of improving patient outcomes through medically integrated oncology practices.

A Continued Commitment to Leadership

This appointment expands upon Dr. Gordan's prior five-year tenure on NCODA's Executive Council, where he was pivotal in providing strategic insights to forward the organization's goals. Now as a member of the Board of Directors, he is set to make even greater contributions to the strategic guidance of NCODA.

Michael Reff, Founder and Executive Director of NCODA, expressed great enthusiasm regarding Dr. Gordan's expanded role on the board. He stated, "Dr. Gordan is a luminary in community oncology. Under his leadership, FCS has accelerated its impact on patients and the overall oncology community. His extensive clinical expertise and unwavering commitment to high-quality, patient-focused care will be instrumental as NCODA continues to support oncology practices and optimize outcomes for cancer patients globally."

Advocacy for Patient Access to Care

Throughout his career, Dr. Gordan has championed initiatives designed to enhance patient access to comprehensive cancer care, focusing on expanding clinical trials and pioneering research programs. His contributions are instrumental in transforming how oncology practices integrate pharmacy services and elevate the quality of patient care—a vision that resonates with NCODA's foundational goals.

As a board member, Dr. Gordan will collaborate closely with NCODA's leadership to boost resources, education, and support for oncology practices facing the complexities of cancer treatment.

"I am honored to join the NCODA Board of Directors and contribute to an organization that is deeply dedicated to the betterment of oncology patient care," Dr. Gordan stated. "NCODA's work in empowering medically integrated practices ensures patients receive exceptional care, and I've seen firsthand its transformative impact. I look forward to advancing its mission alongside the board."

Advancing Oncology Together

Dr. Gordan's appointment symbolizes NCODA's continued commitment to forging partnerships with influential leaders in oncology, driving innovation and advocating for patient access to care. The organization is steadfast in its focus on improving access to high-quality, affordable cancer treatment and supporting practices nationwide through essential resources and guidance.

As part of its mission, NCODA has successfully assisted over 3,000 medically integrated care sites and more than 12,000 professionals globally since its inception in 2015. The organization's goal is clear: to transform oncology care by engaging all stakeholders and ensuring personalized, efficient treatment for those fighting cancer.

To learn more about NCODA and its ongoing initiatives, visit www.ncoda.org.

About NCODA

NCODA is a leading non-profit organization, dedicated to enhancing the quality of oncology care through its commitment to best practices, quality standards, and advocacy. By fostering a medically integrated approach, NCODA aims to optimize patient outcomes while minimizing waste and errors in cancer treatment. The organization continually seeks to provide valuable resources and education to oncology professionals around the world, ensuring the delivery of superior personalized care for cancer patients.